Financials
- Market Capitalization 262.04 M
- Employee 152
- Founded 2016
- CEO N/A
- Website www.entradatx.com
- Headquarter Delaware, United States
- FIGI BBG00MTSMC16
- Industry 생명공학
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
주가수익비율
-3.15
주가매출액비율
91.18
Related tickers
| # | 이름 | 가격 | 24h % | 7d % | 1M % | 1Y % | 마켓 캡 | 이전 7일 | |
|---|---|---|---|---|---|---|---|---|---|
| 3414 | IKT Inhibikase Therapeutics, Inc. - Common Stock | 2.07 USD | +0.49% | -0.48% | +23.95% | +15.00% | 273.31 M USD | ||
| 3419 | ALXO ALX Oncology Holdings Inc. - Common Stock | 1.96 USD | -2.00% | -17.30% | +23.27% | +317.02% | 263.74 M USD | ||
| 3440 | NAGE Niagen Bioscience, Inc. - Common Stock | 3.40 USD | +3.34% | -2.02% | -3.41% | -31.73% | 270.79 M USD | ||
| 3459 | SRZN Surrozen, Inc. - Common Stock | 21.98 USD | +0.46% | -3.34% | -5.22% | +164.18% | 255.20 M USD |